Literature DB >> 1150277

Gm(1) and Gm(2) immunoglobulin allotypes in patients with malignant melanoma.

W Schultheis, H H Peter, H Deicher.   

Abstract

Gm allotype markers were determined in sera from 71 melanoma patients and 400 control persons. There was no significant difference between both groups in Gm distribution. The results were compared to a recent report. Furthermore, in 25 malanoma patients the capacity of serum to interfere with cell-mediated cytotoxicity (CMC) of autologous lymphocytes was determined and related to the Gm allotype.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1150277     DOI： 10.1007/bf00278542

Source DB:  PubMed          Journal:  Humangenetik        ISSN： 0018-7348


  21 in total

1.  [Incidence of Gm serum groups in primary chronic polyarthritis].

Authors:  H DEICHER; E SCHUPP
Journal:  Z Rheumaforsch       Date:  1963-04

Review 2.  Human immunoglobulins: classes, subclasses, genetic variants, and idiotypes.

Authors:  J B Natvig; H G Kunkel
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

3.  [On the genesis of malignant melanomas].

Authors:  G Jörgensen; G F Klostermann
Journal:  HNO       Date:  1968-05       Impact factor: 1.284

4.  [Multiple primary and familial melanoma].

Authors:  G W Korting; G Brehm
Journal:  Z Haut Geschlechtskr       Date:  1969-02-01

5.  Malignant melanoma in siblings.

Authors:  J C Andrews
Journal:  Arch Dermatol       Date:  1968-09

6.  Cancer of the skin.

Authors:  A C Cipollaro
Journal:  Am J Nurs       Date:  1966-10       Impact factor: 2.220

7.  Genetic predisposition to melanoma and other skin cancers in Australians.

Authors:  M M Brown; C A Sharpe; D S Macmillan; V J McGovern
Journal:  Med J Aust       Date:  1971-04-17       Impact factor: 7.738

8.  Serogenetic investigations on malignant melanomas with reference to the incidence of ABO system, Rh system, Gm, Inv, Hp and Ge systems.

Authors:  G Jörgensen; V B Lal
Journal:  Humangenetik       Date:  1972

9.  Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.

Authors:  H H Peter; J R Kalden; P Seeland; V Diehl; G Eckert
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

10.  Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.

Authors:  C O'Toole; V Stejskal; P Perlmann; M Karlsson
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307
View more
  3 in total

1.  On the incidence of blood group O and Gm(-1) phenotypes in patients with malignant melanoma.

Authors:  H Walter; R Brachtel; M Hilling
Journal:  Hum Genet       Date:  1979-05-23       Impact factor: 4.132

2.  Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

Authors:  C N Gaiser; M J Johnson; G de Lange; L Rassenti; L L Cavalli-Sforza; L Steinman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

3.  A linkage study between HLA and cutaneous malignant melanoma or precursor lesions or both.

Authors:  F Demenais; J P Cesarini; M Daveau; B Cavelier; J Gony; N Feingold; J Hors
Journal:  J Med Genet       Date:  1984-12       Impact factor: 6.318
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.